NASDAQ:LIMN | Income Statement | Liminatus Pharma, Inc.

Complete source-backed income-statement history.

Available history
2024-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$600,000.00$1.38M-$1.38M-$28,351.00-$1.41M-$0.03-$0.0348,398,31448,398,314
2026-03-31$400,000.00$1.1M-$1.1M-$22,816.00-$1.12M-$0.03-$0.0335,999,58935,999,589
2025-12-31$884,211.00-$884,211.00-$7.28M-$8.17M-$0.34-$0.341,115,8191,115,819
2025-09-30$701,170.00-$701,170.00-$1.12M-$1.82M-$0.07-$0.0727,007,56827,007,568
2025-06-30$1.12M-$1.12M$1.23M$113,287.00$0.00$0.0023,301,17823,301,178
2025-03-31$264,220.00-$264,220.00-$63,306.00-$327,526.00-$0.02-$0.0217,500,00017,500,000
2024-12-31$0.00$167,077.00-$167,077.00-$62,675.00-$229,752.00-$0.01-$0.0100
2024-09-30$357,066.00$543,147.00-$543,147.00-$58,225.00-$601,372.00-$0.03-$0.0317,500,00017,500,000
2024-06-30$714,134.00$909,218.00-$909,218.00-$51,989.00-$961,207.00-$0.05-$0.0517,500,00017,500,000
2024-03-31-$247.00-$1.75M-$2.47-$2.47100100

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$2.97M-$2.97M-$7.24M-$10.21M-$0.43-$0.4323,753,56123,753,561
2024-12-31$2.69M$3.33M-$3.33M-$216,356.00-$3.55M-$0.20-$0.2017,500,00017,500,000